Suppr超能文献

使用含防腐剂和不含防腐剂的青光眼药物时的眼部症状和体征。

Ocular symptoms and signs with preserved and preservative-free glaucoma medications.

作者信息

Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A, Zeyen T

机构信息

UZ Sint Rafaël, Leuven, Belgium.

出版信息

Eur J Ophthalmol. 2007 May-Jun;17(3):341-9. doi: 10.1177/112067210701700311.

Abstract

PURPOSE

To compare the prevalence of side effects between eyedrops with or without preservatives, in terms of subjective symptoms and objective signs in patients with open-angle glaucoma.

METHODS

In a multicenter cross-sectional epidemiologic survey in four European countries, ophthalmologists in private practice enrolled 9658 nonconsecutive patients using preservative (P) or preservative-free (PF) beta-blocking eyedrops between June 1997 and December 2003. Subjective symptoms, conjunctival and palpebral signs, and superficial punctate keratitis were explored before and after a change in therapy. For statistical analysis, a Chi-square test was used to calculate the differences in the prevalence of symptoms and signs with or without preservatives.

RESULTS

A total of 74% of the patients used P, 12% PF, 10% a P-PF combination, and in 4% the type of medication was unknown. Each recorded symptom and all the palpebral, conjunctival, and corneal signs were significantly more frequent (p<0.0001) in the P-group than in the PF-group, such as pain or discomfort during instillation (48 vs 19%), foreign body sensation (42 vs 15%), stinging or burning (48 vs 20%), and dry eye sensation (35 vs 16%). A total of 68% of the patients had a sec-ond visit performed, of whom 63% (6083) had been evaluated on treatment difference. A significant decrease (p<0.0001) of all ocular symptoms and signs was observed in patients in whom the preserved eyedrops were diminished in number or altered into preservative free drops.

CONCLUSIONS

Compared to preserved eyedrops, preservative free eyedrops are significantly less associated with ocular symptoms and signs of irritation.

摘要

目的

从开角型青光眼患者的主观症状和客观体征方面,比较含防腐剂与不含防腐剂眼药水的副作用发生率。

方法

在四个欧洲国家进行的多中心横断面流行病学调查中,私人执业的眼科医生纳入了1997年6月至2003年12月期间使用含防腐剂(P)或不含防腐剂(PF)的β受体阻滞剂眼药水的9658例非连续患者。在治疗改变前后,对主观症状、结膜和睑部体征以及浅层点状角膜炎进行了探究。为进行统计分析,采用卡方检验计算含或不含防腐剂的症状和体征发生率的差异。

结果

共有74%的患者使用P眼药水,12%使用PF眼药水,10%使用P-PF组合眼药水,4%患者的用药类型未知。P组中每种记录的症状以及所有睑部、结膜和角膜体征的发生率均显著高于PF组(p<0.0001),如滴眼时的疼痛或不适(48%对19%)、异物感(42%对15%)、刺痛或烧灼感(48%对20%)以及干眼感(35%对16%)。共有68%的患者进行了第二次就诊,其中63%(6083例)接受了治疗差异评估。在保存型眼药水数量减少或更换为无防腐剂眼药水的患者中,所有眼部症状和体征均显著减少(p<0.0001)。

结论

与含防腐剂眼药水相比,不含防腐剂眼药水与眼部刺激症状和体征的相关性显著更低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验